HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools Register Now!
Market News Stocks News ETF News Crypto News

FibroBiologics, Inc.

Contributing Author

Recent Articles by FibroBiologics, Inc.

Nov-20
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers FBLG GlobeNewswire
Nov-19
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules FBLG GlobeNewswire
Nov-19
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules FBLG GlobeNewswire
Oct-31
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update FBLG GlobeNewswire
Oct-24
FibroBiologics to Present at Bio-Europe 2025 FBLG GlobeNewswire
Oct-14
FibroBiologics to Present at the 2025 ThinkEquity Conference FBLG GlobeNewswire
Sep-23
FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa FBLG GlobeNewswire
Sep-12
FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies FBLG GlobeNewswire
Sep-11
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment FBLG GlobeNewswire
Sep-10
FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies FBLG GlobeNewswire
Aug-27
FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference FBLG GlobeNewswire
Jul-31
FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update FBLG GlobeNewswire
Jul-28
FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications FBLG GlobeNewswire
Jul-11
FibroBiologics to Present at the Advanced Wound Care Summit USA FBLG GlobeNewswire
Jul-09
FibroBiologics Confirms Ability to Manufacture CybroCell for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank FBLG GlobeNewswire
Jul-07
FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10 FBLG GlobeNewswire
Jun-16
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing FBLG GlobeNewswire
Jun-16
FibroBiologics to Present at the BIO International Convention 2025 FBLG GlobeNewswire
Jun-09
FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer FBLG GlobeNewswire
May-16
FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting FBLG GlobeNewswire
May-14
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update FBLG GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.